Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
European Journal of Pharmacology|January 21, 1983
Central serotonergic activity after neurogenic hypertensionS Giarcovich-Martínez, M Fernandez, E Chemerinski, et al.The American Journal of Psychiatry|January 4, 2001
The specificity of depressive symptoms in patients with Alzheimer's diseaseE Chemerinski, G Petracca, L Sabe, et al.International Psychogeriatrics|November 18, 2000
Impairments of social cognition and decision making in Alzheimer's diseaseT Torralva, F Dorrego, L Sabe, et al.Depression and Anxiety|August 26, 1998
Prevalence and correlates of anxiety in Alzheimer's diseaseE Chemerinski, G Petracca, F Manes, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1996
Two domains of anosognosia in Alzheimer's diseaseS E Starkstein, L Sabe, E Chemerinski, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1996
A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's diseaseG Petracca, A Tesón, E Chemerinski, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 16, 1999
Frontal lobe syndrome reassessed: comparison of patients with lateral or medial frontal brain damageS Paradiso, E Chemerinski, K M Yazici, et al.The British Journal of Psychiatry : the Journal of Mental Science|July 1, 1997
Prospective longitudinal study of depression and anosognosia in Alzheimer's diseaseS E Starkstein, E Chemerinski, L Sabe, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|November 14, 1998
Prevalence and correlates of aggressive behavior in Alzheimer's diseaseE Chemerinski, G Petracca, A Tesón, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
Depression in classic versus akinetic-rigid Parkinson's diseaseS E Starkstein, G Petracca, E Chemerinski, et al.Pageof 3